Newsroom
May 24, 2021
Dr. Alicia Logue, colon and rectal cancer surgery specialist from the Mays Cancer Center for patient care services within the UT Health San Antonio MD Anderson Cancer Center, spoke to News 4 viewers about why the age change for screening is important in the fight against colon and rectal cancers. Watch the story.
May 24, 2021
Dr. Alicia Logue, colon and rectal cancer surgery specialist from the Mays Cancer Center for patient care services within the UT Health San Antonio MD Anderson Cancer Center, spoke to Fox 29 viewers about why the age change for screening is important in the fight against colon and rectal cancers. Watch the story.
May 24, 2021
Dr. Alicia Logue, colon and rectal cancer surgery specialist from the Mays Cancer Center for patient care services within the UT Health San Antonio MD Anderson Cancer Center, spoke to News 4 viewers about why the age change for screening is important in the fight against colon and rectal cancers. Watch the story.
May 21, 2021
Physicians with the Mays Cancer Center, home to UT Health San Antonio MD Anderson, praised the May 18 move by the U.S. Preventive Services Task Force to lower from 50 to 45 the recommended age to begin screening asymptomatic persons to prevent colorectal cancer. The goal is to identify and remove precancerous benign polyps. Physicians nationwide adhere to the panel’s guidelines.
May 21, 2021
Dr. Richard Peterson, Surgery/Metabolic and Bariatric Surgery, and Dr. Ralph DeFronzo, Medicine/Diabetes, are featured in this Lone Star Health News article that highlights the minimally invasive procedure, developed by researchers and physicians at UT Health San Antonio, University Health and Texas Biomedical Research Institute, that is showing promising results to improve patients’ health and minimize […]
May 21, 2021
Dr. Ruben Mesa, executive director of the Mays Cancer Center, is quoted in this excellent AAMC story about five ways that clinical trials may have changed for good, thanks to COVID-19’s forcing researchers to try new ways of running clinical trials. Read the story.